News updates
-
18 SEP
Highlighting challenges in monitoring herbal products and presenting universal recommendations
Lareb conducted a study comprised of semi-structured interviews in order to explore the current ...
-
27 JUN
Prolonged duration of COVID-19 vaccine-induced lymphadenopathy
The Netherlands Pharmacovigilance Centre Lareb has received reports of enlarged lymph nodes after COVID-19 vaccination that do n...
-
30 MAY
Possible ischaemic colitis after bisacodyl use
The Netherlands Pharmacovigilance Centre Lareb received two reports of ischaemic colitis after bisacodyl use. Ischaemic colitis often resolves s...
-
28 MAY
Anaphylactic reaction to the complex of rocuronium and sugammadex
The sugammadex-rocuronium complex can cause severe allergic reactions. Also in patients who are not allergic to one of the in...
-
15 MAY
Agnes Kant appointed as professor at Leiden University
Epidemiologist and director of the Netherlands Pharmacovigilance Centre Lareb, Agnes Kant, has been appointed as professor in pharmacovi...
-
19 APR
Multi-national European cohort event monitoring studies on COVID-19 vaccines
Published results from the multi-national European cohort event monitoring show that most participants experience ...
-
23 JAN
More research needed into Long COVID-like adverse events after COVID-19 vaccination
The Netherlands Pharmacovigilance Centre Lareb has received reports of a combination of adverse events simi...